KRYSTAL DONLEY: Open Payments
NPI 1528682036 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$377 in 13 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $459 · 2025 $377
Food & beverage: $377
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $136 |
| Janssen Pharmaceuticals, Inc | 4 | $95 |
| ABBVIE INC. | 4 | $78 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: INGREZZA, SPRAVATO, VRAYLAR, Auvelity, REXULTI, CAPLYTA.
Industry payments across AZ — which companies pay providers there.
